D-011-2014 Class II Terminated
FDA drug recall D-011-2014 was initiated by Greenstone Llc on Sep 4, 2013 and is designated Class II. Reason for recall: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently… The recall status is terminated (terminated Apr 13, 2017). Affected quantity: 4848 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 27, 2013
- Initiation Date
- Sep 4, 2013
- Termination Date
- Apr 13, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4848 bottles
Product description
Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5012-1
Reason for recall
Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: V121211, Exp 03/31/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-011-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026